Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to $33.3 million.

  • Bruker's Gains from Investment Securities fell 5166.91% to $33.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.6 million, marking a year-over-year increase of 50600.0%. This contributed to the annual value of $48.3 million for FY2024, which is 25046.73% up from last year.
  • As of Q3 2025, Bruker's Gains from Investment Securities stood at $33.3 million, which was down 5166.91% from $11.6 million recorded in Q2 2025.
  • In the past 5 years, Bruker's Gains from Investment Securities ranged from a high of $68.9 million in Q3 2024 and a low of -$51.4 million during Q4 2023
  • Over the past 5 years, Bruker's median Gains from Investment Securities value was $6.9 million (recorded in 2024), while the average stood at $4.3 million.
  • Within the past 5 years, the most significant YoY rise in Bruker's Gains from Investment Securities was 120740.74% (2023), while the steepest drop was 36494.85% (2023).
  • Bruker's Gains from Investment Securities (Quarter) stood at -$3.2 million in 2021, then skyrocketed by 706.25% to $19.4 million in 2022, then tumbled by 364.95% to -$51.4 million in 2023, then skyrocketed by 113.42% to $6.9 million in 2024, then skyrocketed by 382.61% to $33.3 million in 2025.
  • Its Gains from Investment Securities stands at $33.3 million for Q3 2025, versus $11.6 million for Q2 2025 and -$11.2 million for Q1 2025.